ouabain has been researched along with 4-butyrolactone in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukuoka, K; Hirano, T; Hosaka, K; Matsumoto, Y; Mitsuhashi, H; Naito, T; Oka, K | 1 |
Braquet, P; Esanu, A; Fagoo, M; Godfraind, T; Robin, JP | 1 |
Bates, RB; Dolata, DP; Gangwar, S; Gnabre, JN; Pinnas, JL | 1 |
Deslongchamps, P; Phoenix, S; Reddy, MS; Zhang, H | 1 |
4 other study(ies) available for ouabain and 4-butyrolactone
Article | Year |
---|---|
Antiproliferative activity of mammalian lignan derivatives against the human breast carcinoma cell line, ZR-75-1.
Topics: 4-Butyrolactone; Adenosine Triphosphatases; Animals; Benzyl Compounds; Breast Neoplasms; Butylene Glycols; Cell Division; Cell Line; Dogs; Dose-Response Relationship, Drug; Fluorouracil; Humans; Kidney Cortex; Lethal Dose 50; Lignans; Ouabain | 1990 |
Evidence that mammalian lignans show endogenous digitalis-like activities.
Topics: 4-Butyrolactone; Animals; Binding, Competitive; Cross Reactions; Digoxin; Furans; Guinea Pigs; Humans; In Vitro Techniques; Lignans; Myocardium; Ouabain; Radioimmunoassay; Receptors, Drug; Sodium-Potassium-Exchanging ATPase | 1986 |
Tylophora compounds as Na+/K(+)-ATPase inhibitors.
Topics: 4-Butyrolactone; Animals; Basement Membrane; Crystallography, X-Ray; In Vitro Techniques; Kidney Cortex; Models, Molecular; Molecular Conformation; Ouabain; Phenanthrenes; Plants; Rabbits; Saponins; Sodium-Potassium-Exchanging ATPase; Steroids | 1993 |
Total synthesis of ouabagenin and ouabain.
Topics: 4-Butyrolactone; Crystallography, X-Ray; Cyclization; Ouabain; Oxidation-Reduction; Stereoisomerism | 2009 |